View:

Download DOC

Download PDF

Download XLS

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)*

Cross Country Healthcare, Inc. (Name of Issuer)

Common Stock, par value $.0001 (Title of Class of Securities)

227483104 (CUSIP Number)

David J. Snyderman 1603 Orrington Ave., Evanston, IL, 60201 847-905-4400 Magnetar Capital LLC 1603 Orrington Ave., Evanston, IL, 60201 847-905-4400 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

12/31/2024 (Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No.

227483104

1	Name of reporting person Magnetar Financial LLC
2	Check the appropriate box if a member of a Group (See Instructions)   (a)   (b)
3	SEC use only
4	Source of funds (See Instructions) OO
5	Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
6	Citizenship or place of organization DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:	7 Sole Voting Power 0.00 8 Shared Voting Power 2,324,229.00 9 Sole Dispositive Power 0.00 10 Shared Dispositive Power 2,324,229.00
11	Aggregate amount beneficially owned by each reporting person 2,324,229.00
12	Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
13	Percent of class represented by amount in Row (11) 7.20 %
14	Type of Reporting Person (See Instructions) IA, OO

SCHEDULE 13D

CUSIP No.

227483104

1	Name of reporting person Magnetar Capital Partners LP
2	Check the appropriate box if a member of a Group (See Instructions)   (a)   (b)
3	SEC use only
4	Source of funds (See Instructions) OO
5	Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
6	Citizenship or place of organization DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:	7 Sole Voting Power 0.00 8 Shared Voting Power 2,324,229.00 9 Sole Dispositive Power 0.00 10 Shared Dispositive Power 2,324,229.00
11	Aggregate amount beneficially owned by each reporting person 2,324,229.00
12	Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
13	Percent of class represented by amount in Row (11) 7.20 %
14	Type of Reporting Person (See Instructions) HC, OO

SCHEDULE 13D

CUSIP No.

227483104

1	Name of reporting person Supernova Management LLC
2	Check the appropriate box if a member of a Group (See Instructions)   (a)   (b)
3	SEC use only
4	Source of funds (See Instructions) OO
5	Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
6	Citizenship or place of organization DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:	7 Sole Voting Power 0.00 8 Shared Voting Power 2,324,229.00 9 Sole Dispositive Power 0.00 10 Shared Dispositive Power 2,324,229.00
11	Aggregate amount beneficially owned by each reporting person 2,324,229.00
12	Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
13	Percent of class represented by amount in Row (11) 7.20 %
14	Type of Reporting Person (See Instructions) HC, OO

SCHEDULE 13D

CUSIP No.

227483104

1	Name of reporting person David J. Snyderman
2	Check the appropriate box if a member of a Group (See Instructions)   (a)   (b)
3	SEC use only
4	Source of funds (See Instructions) OO
5	Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
6	Citizenship or place of organization UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:	7 Sole Voting Power 0.00 8 Shared Voting Power 2,324,229.00 9 Sole Dispositive Power 0.00 10 Shared Dispositive Power 2,324,229.00
11	Aggregate amount beneficially owned by each reporting person 2,324,229.00
12	Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
13	Percent of class represented by amount in Row (11) 7.20 %
14	Type of Reporting Person (See Instructions) HC, OO

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, par value $.0001
(b)	Name of Issuer: Cross Country Healthcare, Inc.
(c)	Address of Issuer's Principal Executive Offices: 6551 Park of Commerce Blvd NW, Boca Raton, FLORIDA , 33487.
Item 2.	Identity and Background
(a)	Magnetar Financial LLC, a Delaware limited liability company ("Magnetar Financial"), Magnetar Capital Partners LP, a Delaware limited partnership ("Magnetar Capital Partners"), Supernova Management LLC, a Delaware limited liability company ("Supernova Management"), and David J. Snyderman ("Mr. Snyderman") (collectively, the "Reporting Persons").
(b)	1603 Orrington Avenue, 13th Floor, Evanston, Illinois 60201
(c)	Magnetar Financial is a Securities and Exchange Commission ("SEC") registered investment adviser under Section 203 of the Investment Advisers Act of 1940, as amended, and manager of investment funds and managed accounts. Magnetar Financial serves as investment adviser to each of the Funds. In such capacity, Magnetar Financial exercises voting and investment power over the Shares held for the accounts of each of the Funds. Magnetar Capital Partners serves as the sole member and parent holding company of Magnetar Financial. Supernova Management is the general partner of Magnetar Capital Partners. The manager of Supernova Management is Mr. Snyderman. Magnetar Asset Management LLC ("Magnetar Asset Management") is an SEC registered investment adviser and an affiliate of Magnetar Financial. Magnetar Capital Partners serves as the sole member and parent holding company of Magnetar Asset Management. Each of the Funds is a private investment fund; Magnetar Financial is a privately-held SEC registered investment adviser and manager of investment funds and managed accounts; Magnetar Capital Partners is a privately-held limited partnership and serves as the sole member and parent holding company of Magnetar Financial; Supernova Management is a privately-held limited liability company and is the general partner of Magnetar Capital Partners; and Mr. Snyderman is a citizen of the United States of America, manager of Supernova Management and Chief Executive Officer of Magnetar Financial.
(d)	None of the Reporting Persons has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)	None of the Reporting Persons has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which such Reporting Person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws
(f)	Magnetar Financial is a Delaware limited liability company. Magnetar Capital Partners is a Delaware limited partnership. Supernova Management is a Delaware limited liability company. Mr. Snyderman is a citizen of the United States of America.
Item 4.	Purpose of Transaction
	Since the filing of Schedule 13D on December 20, 2024, the Reporting Persons purchased 377,295 Shares between December 19, 2024 and January 2, 2025 reported herein, which consists of 234,221 Shares purchased by the PRA Master Fund, 99,991 Shares purchased by the Systematic Master Fund, 22,272 Shares purchased by the Relative Value Master Fund and 20,811 Shares purchased by the Managed Account. Each of the Reporting Persons reserves the right to acquire additional securities of the Company in the open market, in privately negotiated transactions, or otherwise, to dispose of all or a portion of the Shares and/or other securities reported in this Statement, or to change their intention with respect to any or all of the matters referred to in this Item 4. Other than as described above in this Item 4, the Reporting Persons do not have any plans or proposals that relate to, or would result in, any actions or events specified in clauses (a) through (j) of Item 4 to Schedule 13D.
Item 5.	Interest in Securities of the Issuer
(a)	The Company reported in their Form 8-K Report filed December 4, 2024, that 32,227,395 shares were outstanding as of December 3, 2024. As of the close of business January 2, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 2,324,229 Shares, which consisted of (i) 1,442,879 Shares held for the benefit of the PRA Master Fund and (ii) 615,945 Shares held for the benefit of the Systematic Master Fund, and (iii) 137,207 Shares held for the benefit of the Relative Value Master Fund, and (iv) 128,198 Shares held for the benefit of the Managed Account, and all such Shares represented beneficial ownership of approximately 7.20% of the Shares.
(b)	As of the close of business January 2, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 2,324,229 Shares, which consisted of (i) 1,442,879 Shares held for the benefit of the PRA Master Fund and (ii) 615,945 Shares held for the benefit of the Systematic Master Fund, and (iii) 137,207 Shares held for the benefit of the Relative Value Master Fund, and (iv) 128,198 Shares held for the benefit of the Managed Account, and all such Shares represented beneficial ownership of approximately 7.20% of the Shares.
(c)	Except as set forth on Schedule A attached hereto and Item 6, the Funds had no transactions in the Shares during the 15 days preceding the date of filing of this Statement. All of the transactions set forth on Schedule A attached hereto were effected in the ordinary course of business of Magnetar Financial for the accounts of each of the Funds. The transactions in the Shares set forth on Schedule A were effected in open market transactions on the NASDAQ and various other trading markets.
(d)	No other person is known by the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any Shares that are beneficially owned by the Reporting Persons.
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the Reporting Persons have entered into an agreement with respect to the joint filing of this Statement, and any amendment or amendments hereto. Except as otherwise described herein, no contracts, arrangements, understandings or similar relationships exist with respect to the securities of the Company among or between the Reporting Persons or any other person or entity.
Item 7.	Material to be Filed as Exhibits.
	99.1 Joint Filing Agreement, dated as of January 3, 2025, among the Reporting Persons 99.2 Power of Attorney, dated as of December 22, 2022 filed by the Reporting Persons on January 3, 2025. 99.3. Schedule A

SIGNATURE
	After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Magnetar Financial LLC

Signature: /s/ Hayley Stein Name/Title: Hayley Stein/Attorney-in-fact for David J. Snyderman, Manager of Supernova Management LLC Date: 01/03/2025

Magnetar Capital Partners LP

Signature: /s/ Hayley Stein Name/Title: Hayley Stein/Attorney-in-fact for David J. Snyderman, Manager of Supernova Management LLC Date: 01/03/2025

Supernova Management LLC

Signature: /s/ Hayley Stein Name/Title: Hayley Stein/Attorney-in-fact for David J. Snyderman, Manager Date: 01/03/2025

David J. Snyderman

Signature: /s/ Hayley Stein Name/Title: Hayley Stein/Attorney-in-fact for David J. Snyderman Date: 01/03/2025

Comments accompanying signature: MAGNETAR FINANCIAL LLC By: Magnetar Capital Partners LP, its Sole Member MAGNETAR CAPITAL PARTNERS LP By: Supernova Management LLC, its General Partner

EXHIBIT 99.2

LIMITED POWER OF ATTORNEY

Know all by these present, that I, David J. Snyderman, hereby make, constitute and appoint each of Michael Turro, Karl Wachter and Hayley Stein, or any of them acting individually, and with full power of substitution, as my true and lawful attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as Manager or in other capacities of Supernova Management LLC, a Delaware limited liability company, and each of its affiliates or entities advised or controlled by me or Supernova Management LLC, all documents, certificates, instruments, statements, filings and agreements (“documents”) to be filed with or delivered to the United States Securities and Exchange Commission (the “SEC”) pursuant to the Securities and Exchange Act of 1934, as amended (the “Act”), and the rules and regulations promulgated thereunder, including, without limitation, all documents relating to the beneficial ownership of securities required to be filed with the SEC pursuant to Section 13(d) or Section 16(a) of the Act, including, without limitation: (a) any acquisition statements on Schedule 13D or Schedule 13G and any amendments thereto, (b) any joint filing agreements pursuant to Rule 13d-1(k) under the Act, and (c) any initial statements of, or statements of changes in, beneficial ownership of securities on Form 3, Form 4 or Form 5.

All past acts of the attorney-in-fact in furtherance of the foregoing are hereby ratified and confirmed.

This Power of Attorney shall remain in full force and effect until the earlier of it being (a) revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact or (b) superseded by a new power of attorney regarding the purposes outlined herein as of a later date.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 22 day of December, 2022.

Exhibit 99.3

SCHEDULE A

Funds

TB(1) Excludes commissions and other execution-related costs.

(2) Upon request by the staff of the Securities and Exchange Commission, full information regarding the number of shares bought or sold (as the case may be) at each separate price will be provided.

(3) Reflects a weighted average purchase price of $17.92479 per share, at prices ranging from $17.9 to $17.95 per share.

(4) Reflects a weighted average purchase price of $17.88283 per share, at prices ranging from $17.84 to $17.91 per share.

(5) Reflects a weighted average purchase price of $17.94974 6per share, at prices ranging from $17.9 to $17.97 per share.

(6) Reflects a weighted average purchase price of $17.96386 per share, at prices ranging from $17.9 to $18.00 per share.

(7) Reflects a weighted average purchase price of $17.98054 per share, at prices ranging from $17.95 to $18.00 per share.

(8) Reflects a weighted average purchase price of $18.00899 per share, at prices ranging from $17.96 to $18.08 per share.

(9) Reflects a weighted average purchase price of $18.11968 per share, at prices ranging from $18.08 to $18.15 per share.

(10) Reflects a weighted average purchase price of $18.11946 per share, at prices ranging from $18.01 to $18.15 per share.